Join
Live feed
·
PRReleasevia Quantisnow
Bruker Corporation logo

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

ByQuantisnow·Wall Street's wire, on your screen.
BRKR· Bruker Corporation
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BRKR (Bruker Corporation) and more on Quantisnow.